SCHEMBL7548266

SCHEMBL7548266

NCc1ccc(C(C(N)=O)C2CCc3cc(Cl)cc4[nH]c(C(=O)O)c2c34)c(CCC(=O)O)c1

nearest known ligand 0.39

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR17 Q13304 9/20 0.39
FBP1 P09467 1/20 0.39
GRIN1 Q05586 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7551403 0.94 GPR17 (0.35) GPR17FBP1GRIN1
SCHEMBL7555553 0.92 GRIN1 (0.32) GPR17FBP1GRIN1
Hydrochloric Acid SCHEMBL7554193 0.91 GRIN1 (0.32) GPR17FBP1GRIN1
SCHEMBL7550571 0.88 GRIN1 (0.33) GPR17FBP1GRIN1
SCHEMBL7549048 0.85 PTGDR (0.32) GPR17FBP1GRIN1
Hydrochloric Acid SCHEMBL7547498 0.84 PTGDR (0.32) GPR17FBP1GRIN1
SCHEMBL7551083 0.80 ACE2 (0.33)
SCHEMBL7548907 0.78 L3MBTL1 (0.32) GRIN1
SCHEMBL7548276 0.78 GPR17 (0.38) GPR17FBP1GRIN1
SCHEMBL7553550 0.77 GPR17 (0.31) GPR17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0657427-B1 Tricyclic indole-2-carboxylic acid derivatives being selective antagonists of the NMDA receptor SUMITOMO PHARMA (JP) 2002-06-19 EP disclosed
US-5496843-A Tricyclic indole-2-carboxylic acid derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-03-05 US disclosed
EP-0657427-A1 Tricyclic indole-2-carboxylic acid derivatives being selective antagonists of the NMDA receptor SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1995-06-14 EP disclosed